Chicago can­cer tech startup teams up with Mayo Clinic

Modern Healthcare - - REGIONAL NEWS -

Tem­pus, a Chicago-based can­cer tech­nol­ogy startup, has signed a part­ner­ship with the Mayo Clinic.

The com­pany will pro­vide ge­netic se­quenc­ing and anal­y­sis for 1,000 pa­tients in two clin­i­cal tri­als in­volv­ing can­cer pa­tients.

Tem­pus was formed a lit­tle more than a year ago and has about 100 em­ploy­ees. It’s lo­cated in the same

build­ing as Groupon and sev­eral other com­pa­nies co-founded by Eric Le­fkof­sky and busi­ness part­ner Brad Key­well. The com­pany aims to help doc­tors choose the most ef­fec­tive treat­ments, based on the pa­tient’s in­di­vid­ual ge­netic pro­files.

It has signed part­ner­ships with sev­eral other univer­sity re­search cen­ters, in­clud­ing North­west­ern’s Lurie Can­cer Cen­ter, Rush Univer­sity Med­i­cal Cen­ter, the Univer­sity of Penn­syl­va­nia’s Abram­son Can­cer Cen­ter and Univer­sity of Michi­gan.

Newspapers in English

Newspapers from USA

© PressReader. All rights reserved.